Actin-binding protein anillin promotes the progression of hepatocellular carcinoma in vitro and in mice.

Jia H, Gao Z, Yu F, Guo H, Li B

DOI: 10.3892/etm.2021.9885
Published: 2021 May
Container: Experimental and therapeutic medicine
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3892/etm.2021.9885,
  title = {Actin-binding protein anillin promotes the progression of hepatocellular carcinoma in vitro and in mice.},
  author = {Jia H and Gao Z and Yu F and Guo H and Li B},
  year = {2021},
  journal = {Experimental and therapeutic medicine},
  doi = {10.3892/etm.2021.9885},
  url = {https://doi.org/10.3892/etm.2021.9885}
}

RIS

TY  - JOUR
TI  - Actin-binding protein anillin promotes the progression of hepatocellular carcinoma in vitro and in mice.
AU  - Jia H
AU  - Gao Z
AU  - Yu F
AU  - Guo H
AU  - Li B
PY  - 2021
JO  - Experimental and therapeutic medicine
DO  - 10.3892/etm.2021.9885
UR  - https://doi.org/10.3892/etm.2021.9885
ER  -

APA

H, J., Z, G., F, Y., H, G., & B, L. (2021). Actin-binding protein anillin promotes the progression of hepatocellular carcinoma in vitro and in mice.. Experimental and therapeutic medicine. https://doi.org/10.3892/etm.2021.9885

Source records

pubmed · retrieved 2026-09-25T21:16:50.335Z